Melatonin for sleep problems in children with neurodevelopmental disorders

    Insights

    Children with neurodevelopmental disorders often experience insomnia. This review examines the off-label use of melatonin, a sleep hormone, for treating sleep issues in children with ADHD or autism spectrum disorder.

    Area of Science:

    • Pediatric Sleep Medicine
    • Neurodevelopmental Disorders
    • Pharmacology

    Background:

    • Children with neurodevelopmental disorders frequently suffer from sleep disturbances, including difficulty falling asleep, irregular sleep-wake cycles, and reduced sleep duration.
    • These sleep problems may be linked to disruptions in the natural secretion of melatonin, a hormone crucial for regulating the sleep-wake cycle.
    • Previous research reviewed melatonin use in older adults; this study focuses on pediatric populations.

    Purpose of the Study:

    • To review the off-label and unlicensed use of melatonin for sleep problems in children with neurodevelopmental disorders.
    • To evaluate the current evidence regarding melatonin's efficacy and safety in this specific pediatric group.

    Main Methods:

    • Literature review of studies on melatonin use in children with attention-deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
    • Analysis of data concerning sleep onset, sleep duration, and behavioral outcomes.
    • Assessment of reported side effects and safety profiles.

    Main Results:

    • Children with ADHD and ASD exhibit high rates of insomnia and circadian rhythm disruptions.
    • Melatonin is frequently used off-label to manage these sleep issues in pediatric populations.
    • Evidence on efficacy and long-term safety in children with neurodevelopmental disorders is still developing.

    Conclusions:

    • Melatonin shows potential as a therapeutic option for sleep disturbances in children with ADHD and ASD.
    • Further rigorous research is needed to establish optimal dosing, long-term efficacy, and safety.
    • Clinical guidelines for melatonin use in pediatric neurodevelopmental disorders require further evidence-based development.

    Related Concept Videos

    Management of Insomnia01:19

    Management of Insomnia

    The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
    778
    Nightmares and Night Terrors01:18

    Nightmares and Night Terrors

    Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
    Nightmares...
    812
    Narcolepsy01:07

    Narcolepsy

    Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
    772
    Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

    Sedatives and Hypnotics Drugs: Miscellaneous Agents

    Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
    Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
    849
    REM Sleep Behavior Disorder01:15

    REM Sleep Behavior Disorder

    REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
    RBD is significantly associated with...
    2.5K
    Understanding Sleep01:11

    Understanding Sleep

    Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
    The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
    1.8K